Clinical Trials Directory

Trials / Completed

CompletedNCT03916523

Sustained Lung Inflation With CPAP in Preterm Neonates (SI-CPAP)

Effect of Sustained Lung Inflation During CPAP in Preterm Neonates With Respiratory Distress Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
6 Hours
Healthy volunteers
Not accepted

Summary

Neonatal respiratory distress syndrome (RDS) is the most common cause of respiratory failure in the first few days in life. It is characterized by the tendency of alveoli and terminal bronchioles to collapse due to the lack of surfactant. RDS is inversely related to gestational age and remains a dominant clinical problem encountered among preterm infants. The reduction in tidal volume secondary to alveolar collapse may result in alveolar derecruitment, cyclic opening and closing of atelectatic alveoli and distal small airways leading to inflammation and lung injury). On the other hand, the use of high positive end expiratory pressure (PEEP) may be associated with excessive lung parenchyma strain and unfavorable hemodynamic effects. Therefore, lung recruitment maneuvers have been proposed and used to open collapsed lung while managing with low pressure PEEP. However, the best recruitment maneuver technique is currently unknown. Proinflammatory cytokines are synthesized by alveolar macrophages, type II pneumocytes and other local pulmonary cells causing inflammation that starts a cascade leading to lung injury. Nevertheless, they are released systemically and can lead to injury of other organs. This study aims to measure inflammatory cytokines in the serum of premature infants who receive and do not receive sustained lung inflation. The study hypothesis is that, in premature infants supported with CPAP, the use of sustained inflation is associated with decreased inflammatory biomarkers and improved respiratory outcomes. The study includes infants with gestational age of 28-24 weeks during the first 6 hours of life who will be randomly assigned to either receive (or do not receive) sustained inflations. Serum concentrations of cytokines (IL-6, IL-8, IL-1β and TNF-α) will be measured at enrollment and at 96 hours. The primary outcome of this study will be the change in serum cytokine concentrations after intervention in both groups. Clinical respiratory outcomes will be monitored.

Conditions

Interventions

TypeNameDescription
PROCEDURESustained lung inflationPreterm infants will receive a total of 15 sustained lung inflations during the first 4 days of life as follows: 1. On day 1 of life (a total of 6 sustained lung inflations, 20 cmH2O for 21 seconds each) once at enrollment and then once every 4 hours 2. On day 2 of life (a total of 3 sustained lung inflations, 15 cmH2O for 21 seconds each) once every 8 hours. 3. On day 3 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours. 4. On day 4 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours.
PROCEDUREContinuous positive airway pressure (CPAP)Preterm infants will receive CPAP for respiratory support.
PROCEDUREMechanical ventilationPreterm infants in this group will receive mechanical ventilation for respiratory support

Timeline

Start date
2013-01-01
Primary completion
2016-03-15
Completion
2016-03-15
First posted
2019-04-16
Last updated
2019-04-18

Source: ClinicalTrials.gov record NCT03916523. Inclusion in this directory is not an endorsement.